Integrity Medical Product Solutions, LLC v. Seroclinix Corporation, a Delaware Corporation, et. al.

CourtDistrict Court, S.D. California
DecidedOctober 22, 2025
Docket3:22-cv-00785
StatusUnknown

This text of Integrity Medical Product Solutions, LLC v. Seroclinix Corporation, a Delaware Corporation, et. al. (Integrity Medical Product Solutions, LLC v. Seroclinix Corporation, a Delaware Corporation, et. al.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Integrity Medical Product Solutions, LLC v. Seroclinix Corporation, a Delaware Corporation, et. al., (S.D. Cal. 2025).

Opinion

1 2 3 4 5 6 7 8 9 10 11 UNITED STATES DISTRICT COURT 12 SOUTHERN DISTRICT OF CALIFORNIA 13 14 INTEGRITY MEDICAL PRODUCT Case No. 22-cv-00785-BAS-BLM SOLUTIONS, LLC, 15 ORDER GRANTING THIRD-PARTY Plaintiff, 16 DEFENDANT HONU v. MANAGEMENT GROUP, LLC’S 17 MOTION TO DISMISS (ECF No. 88) SEROCLINIX CORPORATION, a 18 Delaware Corporation, et. al,

19 Defendants. 20 SEROCLINIX CORPORATION, a 21 Delaware Corporation, and SEROCLINIX CORPORATION, a Canadian 22 Corporation, 23 Third-Party Plaintiffs, 24 v. 25 HONU MANAGEMENT GROUP, LLC, 26 an Arizona Limited Liability Company, 27 Third-Party Defendant. 28 1 Presently before the Court is Third-Party Defendant Honu Management Group, 2 LLC’s motion to dismiss the amended complaint filed by Third-Party Plaintiffs Seroclinix 3 Corporation, a Delaware corporation (“Seroclinix Delaware”) and Seroclinix Corporation, 4 a Canadian corporation (“Seroclinix Canada”) (ECF No. 85). (ECF No. 88.) 5 I. BACKGROUND 6 Plaintiff Integrity, Inc. had entered into an agreement with Third-Party Plaintiff 7 Seroclinix Delaware to sell laboratory testing kits. (ECF No. 85 ¶ 10.) The Integrity- 8 Seroclinix Agreement provided, in part, that Integrity’s end-customers were to pay 9 Seroclinix Delaware directly, with Seroclinix Delaware paying a commission to Integrity 10 in the amount of the difference between the stated unit price in the Integrity-Seroclinix 11 Agreement and the amount charged by Integrity to its end-customer. (Id.) During the 12 Covid-19 pandemic, there was a heightened demand for test kits that led to Seroclinix 13 Delaware and Integrity orally modifying the terms of the Integrity-Seroclinix Agreement 14 to, in part, provide that Integrity would be paid a commission of $0.90 per test kit ordered 15 by its end-consumers, such as Third-Party Defendant Honu, upon full receipt for the test 16 kits by Seroclinix Delaware. (Id. ¶ 11.) 17 Third-Party Defendant Honu Management, LLC (“Honu”) entered into a contract 18 for laboratory testing kits with Akkad Holdings Global (“Akkad-Honu Agreement”) on 19 August 6, 2020. (Id. ¶ 12.) According to the Akkad-Honu Agreement, Akkad Holdings 20 Global was acting on behalf of Seroclinix Canada when entering into the contract. (Id.) 21 Seroclinix Delaware is a third-party beneficiary of the contract, as payments for inventory 22 ordered by Defendant Honu were ultimately received by Seroclinix Delaware. (Id.) 23 In their amended complaint against Honu (ECF No. 85) (“TPC”), Seroclinix 24 Delaware and Seroclinix Canada alleged that Honu breached the Akkad-Honu Agreement 25 by refusing to order and accept delivery of 50,000 units per week and owed them a sum of 26 $938,000 plus interest for expired test kits of which Honu failed and refused to take 27 delivery, plus interest of one percent (1%) per month from the date of its breach. (Id. ¶ 28 19.) Seroclinix Canada and Seroclinix Delaware asserted causes of action against Honu 1 for: (1) breach of contract of the Akkad-Honu agreement; (2) contractual indemnity to 2 Seroclinix Canada and Seroclinix Delaware for claims against Third-Party Plaintiffs 3 asserted by Plaintiff Integrity Medical Product Solutions, LLC in this action; (3) implied 4 indemnity for the same; and (4) intentional misrepresentation of Honu’s intention to meet 5 financial obligations to Seroclinix Delaware and Seroclinix Canada specified in the Akkad- 6 Honu Agreement. (See generally id.) 7 In response to the TPC (ECF No. 85), Honu filed a motion to dismiss (ECF No. 88) 8 (“TPMTD”). In the TPMTD, Honu alleges, inter alia, that: (1) the Court lacks personal 9 jurisdiction over Honu; (2) the TPC fails to adequately plead fraud or mistake under Rule 10 9(b) and California state law; (3) the TPC fails to allege actual loss necessary for adequately 11 pleading an implied indemnity claim; (4) the TPC is barred by California’s four-year statute 12 of limitations for breach of contract claims, and contrary to the TPC, New York’s six-year 13 statute of limitations does not apply to the present dispute. (See generally ECF No. 88.) 14 Third-Party Plaintiffs filed an opposition to Honu’s motion to dismiss (“TPO”), contesting, 15 inter alia, that the Court has specific jurisdiction over Honu in California. (ECF No. 91 at 16 8–12.) Honu filed a reply. (ECF No. 92.) 17 II. LEGAL STANDARD 18 When raised as a defense by motion, Rule 12(b)(2) authorizes the dismissal of an 19 action for lack of personal jurisdiction. See Fed. R. Civ. P. 12(b)(2). When a dispute 20 between the parties arises concerning whether personal jurisdiction over a defendant is 21 proper, “the plaintiff bears the burden of demonstrating that jurisdiction is appropriate.” 22 Will Co. v. Lee, 47 F.4th 917, 921 (9th Cir. 2022). When the defendant’s motion is based 23 on written materials, and no evidentiary hearing is held, the court will evaluate only 24 whether the plaintiff demonstrates a prima facie showing of personal jurisdiction based on 25 the plaintiff’s pleadings and affidavits. Id. The court must take unchallenged allegations 26 in the complaint as true, and conflicts between the parties over statements within any 27 affidavits must be resolved in favor of the plaintiff. Id. 28 1 III. DISCUSSION 2 The general rule provides personal jurisdiction over a defendant is proper if it is 3 permitted by a long-arm statute and if the exercise of that jurisdiction does not violate 4 federal due process. Pebble Beach Co. v. Caddy, 453 F.3d 1151, 1154 (9th Cir. 2006). For 5 due process to be satisfied, a defendant must have “minimum contacts” within the forum 6 state such that asserting jurisdiction over the defendant would not “offend traditional 7 notions of fair play and substantial justice.” Id. at 1155 (citing Int’l Shoe Co. v. 8 Washington, 326 U.S. 310, 315 (1945)). Both California and federal long-arm statutes 9 require compliance with due process requirements. Daimler AG v. Bauman, 571 U.S. 117, 10 125 (2014). 11 There are two types of personal jurisdiction: general and specific. Id. at 118. 12 General jurisdiction allows a court to hear cases unrelated to the defendant’s forum 13 activities and exists if the defendant has “substantial” or “continuous and systematic” 14 contacts with the forum state. Fields v. Sedgewick Assoc. Risk, Ltd., 769 F.2d 299, 301 15 (9th Cir. 1986). Specific jurisdiction permits the court to exercise jurisdiction over a 16 defendant who has availed itself through forum-related activities that gave rise to the action 17 before the court. Bancroft & Masters, Inc. v. August Nat’l Inc., 223 F.3d 1082, 1086 (9th 18 Cir. 2000). 19 Here, Honu challenges Third-Party Plaintiffs’ assertion of personal jurisdiction on 20 grounds of lack of general jurisdiction and lack of specific jurisdiction. (ECF No. 88-1 at 21 14.) 22 A. General Jurisdiction 23 First, Honu asserts it is not subject to general jurisdiction in California because its 24 principal place of business is in Washington, and it is not otherwise “at home” in California. 25 (Id. at 14:20–23 (citing Impossible Foods, Inc. v. Impossible X LLC, 80 F.4th 1079, 1086 26 (9th Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Sher v. Johnson
911 F.2d 1357 (Ninth Circuit, 1990)
Daimler AG v. Bauman
134 S. Ct. 746 (Supreme Court, 2014)
Walden v. Fiore
134 S. Ct. 1115 (Supreme Court, 2014)
Bernard Picot v. Dean Weston
780 F.3d 1206 (Ninth Circuit, 2015)
Joseph Pakootas v. Teck Cominco Metals, Ltd.
905 F.3d 565 (Ninth Circuit, 2018)
Ama Multimedia, LLC v. Marcin Wanat
970 F.3d 1201 (Ninth Circuit, 2020)
Jones v. Resolution Trust Corp.
7 F.3d 1006 (Eleventh Circuit, 1993)
Will Co., Ltd. v. Ka Lee
47 F.4th 917 (Ninth Circuit, 2022)
Schwarzenegger v. Fred Martin Motor Co.
374 F.3d 797 (Ninth Circuit, 2004)
Impossible Foods Inc. v. Impossible X LLC
80 F.4th 1079 (Ninth Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Integrity Medical Product Solutions, LLC v. Seroclinix Corporation, a Delaware Corporation, et. al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/integrity-medical-product-solutions-llc-v-seroclinix-corporation-a-casd-2025.